{"nct_id":"NCT02177812","title":"A Phase I Dose Escalation Study of GSK2879552 in Subjects With Acute Myeloid Leukemia (AML)","status":"TERMINATED","status_verified_date":"2019-04","start_date":"2014-08-27","start_date_type":"ACTUAL","primary_completion_date":"2017-12-08","primary_completion_date_type":"ACTUAL","completion_date":"2017-12-08","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["GSK"]}